A
Arthur L. Caplan
Researcher at New York University
Publications - 700
Citations - 15574
Arthur L. Caplan is an academic researcher from New York University. The author has contributed to research in topics: Transplantation & Bioethics. The author has an hindex of 57, co-authored 664 publications receiving 13978 citations. Previous affiliations of Arthur L. Caplan include University of Strasbourg & University of Pittsburgh.
Papers
More filters
Book
Am I My Brother’s Keeper?: The Ethical Frontiers of Biomedicine
TL;DR: This chapter discusses research, experimentation and innovation, health policy, ethics and the use of Living Donors, and the ethics of Gatekeepers in the context of the total artificial heart.
Journal ArticleDOI
Living donation: focus on public concerns
TL;DR: A multidisciplinary group of leading experts and stakeholders was called to assess the current status of living donation and suggest productive changes to ensure safer and more ethically sound procedures for both donors and recipients.
Journal ArticleDOI
An alternative proposal to the destruction of abandoned human embryos.
TL;DR: It is proposed that the continued implementation of the Cartagena Protocol is more likely to lead to barriers than solutions, and non-governmental organizations are already asserting that genome-editing techniques are essentially genetic modification, whereas other agencies take the opposing view.
Journal ArticleDOI
Health care reform in Minnesota.
TL;DR: On April 23, Minnesota enacted complex and far-reaching legislation to reform health care, which reform health insurance practices, establish a state-subsidized, sliding-scale health insurance plan, and propose to consolidate the state's health care bureaucracy.
Journal ArticleDOI
Longer-term outcomes after kidney transplantation from seronegative deceased donors at increased risk for blood-borne viral infection.
Peter P. Reese,Scott D. Halpern,David A. Asch,Roy D. Bloom,Howard M. Nathan,Richard Hasz,Joseph Roth,William Reitsma,Louis Krefski,Fred Goerlitz,Gina DeLauro,Emily A. Blumberg,Francis L. Weng,Arthur L. Caplan,Arwin Thomasson,Justine Shults,Harold I. Feldman +16 more
TL;DR: DIRVI kidney recipients experienced higher mortality than standard criteria kidney recipients and could be explained if sicker patients received DIRVI kidneys (i.e., residual confounding) or the less likely possibility of undetected transmission of viral infections.